TheadvantageofLowMolecularweightHeparinsoverregularheparinsislargelyduetotheirlowermolecularweightandshorterpolysaccharidechainlength,whichallowsthemtobindlessnonspecificallytocellsurfaceandplasmaprot
Severallow-molecular-molecule(LMW)heparinpreparations,includingdapheparin,enoxaparinandnaxiparin,aswellasHeparinoiddanaparinsodium,areapprovedforuseinAustralia.Lowmolecularweightheparinisreplacingregu
Heparinsodiumisalsoacommonpharmaceuticalintermediate,whichisgenerallyusedasanadditiveforvascularcollectioninclinicalpractice.Thespecification,performanceandpackagingoftheproductarethekeypointsthatwene
Asfarasheparinsodiumisconcerned,ithasagoodanticoagulanteffectinhumanbody.Ithasgoodtherapeuticeffectineffectivelyinhibitingthrombinformationandimprovingbloodcirculation.Ithasbecomeacommondruginthecurre